Their smaller size typically enables more straightforward synthesis and formulation processes
weight loss at target dose (trial data) ~15% (STEP 1) CV risk reduction labelled Yes (SELECT obesity + CVD) Format Prefilled pen India price (May 2026) 5,66016,400/month (Poviztra co-marketed: 3,9998,999/month) DCGI-approved Yes (20252026) Generic competition in India n/a (innovator) Generic semaglutide 9+ Indian manufacturers Active molecule Semaglutide Receptor activity GLP-1 Primary indication T2D &/or obesity (brand-dependent) Max maintenance dose 0.52.4 mg weekly Avg
Emerging research suggests that GLP-1 receptor agonists can cross the blood-brain barrier, making them potential treatments for neuroinflammatory and neurodegenerative diseases like Alzheimers, Parkinsons, and multiple sclerosis (MS)
Rest and activity modification typically resolve it
"L-Arginine Nitric Oxide Supplement": This phrase reflects the active ingredients listed on the Vital Blood Supplement Facts label (L-Arginine HCL, L-Arginine Alpha-Ketoglutarate, L-Citrulline Malate)
